Ron Najafi

Dr. Ramin (“Ron”) Najafi is the founder, chairman and CEO of NovaBay Pharmaceuticals (NYSE-Amex: NBY), a clinical stage biopharmaceutical company developing first-in-class anti-infectives for treating and preventing antibiotic-resistant infections. An accomplished entrepreneur and scientist, Dr. Najafi has founded three companies, and has held numerous executive and scientific roles in the biopharmaceutical industry over the past 20 years.

Page 1 of 1